These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 3495333

  • 21. Exogenous human recombinant interleukin-10 attenuates hindlimb ischemia-reperfusion injury.
    Engles RE, Huber TS, Zander DS, Hess PJ, Welborn MB, Moldawer LL, Seeger JM.
    J Surg Res; 1997 May; 69(2):425-8. PubMed ID: 9224418
    [Abstract] [Full Text] [Related]

  • 22. Albumin impacts the effects of tonicity on microvascular hydraulic permeability.
    Victorino GP, Chong TJ, Curran B.
    J Surg Res; 2004 Dec; 122(2):167-72. PubMed ID: 15555615
    [Abstract] [Full Text] [Related]

  • 23. Low dose subcutaneous interleukin-2 after autologous transplantation generates sustained in vivo natural killer cell activity.
    Miller JS, Tessmer-Tuck J, Pierson BA, Weisdorf D, McGlave P, Blazar BR, Katsanis E, Verfaillie C, Lebkowski J, Radford J, Burns LJ.
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):34-44. PubMed ID: 9209739
    [Abstract] [Full Text] [Related]

  • 24. Tumor growth suppression by a mouse/human chimeric anti-CEA antibody and lymphokine-activated killer cells in vitro and in SCID mouse xenograft model.
    Senba T, Kuroki M, Arakawa F, Yamamoto T, Kuwahara M, Haruno M, Ikeda S, Matsuoka Y.
    Anticancer Res; 1998 Apr; 18(1A):17-24. PubMed ID: 9568050
    [Abstract] [Full Text] [Related]

  • 25. Dibutyryl cAMP prevents increased vascular permeability caused by air embolism in isolated rat lungs.
    Hsu K, Huang KL, Wang D, Hsu CS, Chiang CH.
    Aviat Space Environ Med; 1997 Sep; 68(9):802-6. PubMed ID: 9293348
    [Abstract] [Full Text] [Related]

  • 26. Lymphokine-activated killer cells: culture conditions for the generation of maximal in vitro cytotoxicity in cells from normal donors.
    Beckner SK, Maluish AE, Longo DL.
    Cancer Res; 1987 Oct 15; 47(20):5504-8. PubMed ID: 3498534
    [Abstract] [Full Text] [Related]

  • 27. Interleukin-12 synergizes with interleukin-2 to generate lymphokine-activated killer activity in peripheral blood mononuclear cells cultured in ovarian cancer ascitic fluid.
    Barton DP, Blanchard DK, Duan C, Roberts WS, Cavanagh D, DeCesare S, Djeu JY.
    J Soc Gynecol Investig; 1995 Oct 15; 2(6):762-71. PubMed ID: 9420887
    [Abstract] [Full Text] [Related]

  • 28. Effect of interleukin-2 on microvascular liquid and protein transport in the rat small intestine.
    Stuntz ME, Witte MH, Witte CL, Way DL, Champsi JH, Finley PR.
    Lymphology; 1990 Sep 15; 23(3):149-54. PubMed ID: 2250485
    [Abstract] [Full Text] [Related]

  • 29. Systemic administration of recombinant interleukin 2 stimulates in vivo lymphoid cell proliferation in tissues.
    Ettinghausen SE, Lipford EH, Mulé JJ, Rosenberg SA.
    J Immunol; 1985 Aug 15; 135(2):1488-97. PubMed ID: 3891854
    [Abstract] [Full Text] [Related]

  • 30. Effect of tumor irradiation on the uptake of lymphokine-activated killer cells in a murine tumor model.
    Munshi NC, Williams JR.
    Cancer Res; 1994 Apr 01; 54(7):1657-9. PubMed ID: 8137277
    [Abstract] [Full Text] [Related]

  • 31. Inhibition of nitric oxide synthase reverses the effect of albumin on lung damage in burn.
    Chen LW, Hwang YC, Wang JS, Chen JS, Hsu CM.
    J Am Coll Surg; 2005 Apr 01; 200(4):574-83. PubMed ID: 15804472
    [Abstract] [Full Text] [Related]

  • 32. Bleomycin-induced changes in pulmonary microvascular albumin permeability and extravascular albumin space.
    Wangensteen D, Yankovich R, Hoidal J, Niewoehner D.
    Am Rev Respir Dis; 1983 Feb 01; 127(2):204-8. PubMed ID: 6187252
    [Abstract] [Full Text] [Related]

  • 33. IL-2 induces pulmonary edema and vasoconstriction independent of circulating lymphocytes.
    Ferro TJ, Johnson A, Everitt J, Malik AB.
    J Immunol; 1989 Mar 15; 142(6):1916-21. PubMed ID: 2784141
    [Abstract] [Full Text] [Related]

  • 34. Effects of protamine, heparinase, and hyaluronidase on endothelial permeability and surface charge.
    Sunnergren KP, Fairman RP, deBlois GG, Glauser FL.
    J Appl Physiol (1985); 1987 Nov 15; 63(5):1987-92. PubMed ID: 3693232
    [Abstract] [Full Text] [Related]

  • 35. Effects of PEG-coupled interleukin-2 on rat lung lavage parameters.
    Moon HL, Olsen E, Nachtman J.
    Biotechnol Ther; 1987 Nov 15; 1(3):203-12. PubMed ID: 2562775
    [Abstract] [Full Text] [Related]

  • 36. Effects of lactoferrin on rat dermal interstitial fluid pressure (Pif) and in vitro endothelial barrier function.
    Erga KS, Peen E, Enestrøm S, Reed RK.
    Acta Physiol Scand; 2001 Apr 15; 171(4):419-25. PubMed ID: 11421857
    [Abstract] [Full Text] [Related]

  • 37. Interleukin 2-induced increase of vascular permeability without decrease of the intravascular albumin pool.
    Ballmer-Weber BK, Dummer R, Küng E, Burg G, Ballmer PE.
    Br J Cancer; 1995 Jan 15; 71(1):78-82. PubMed ID: 7819054
    [Abstract] [Full Text] [Related]

  • 38. Microvascular albumin permeability in isolated perfused lung: effects of EDTA.
    Kern DF, Malik AB.
    J Appl Physiol (1985); 1985 Feb 15; 58(2):372-5. PubMed ID: 3920186
    [Abstract] [Full Text] [Related]

  • 39. Evans blue dye in the assessment of permeability-surface area product in perfused rat lungs.
    Dallal MM, Chang SW.
    J Appl Physiol (1985); 1994 Aug 15; 77(2):1030-5. PubMed ID: 8002488
    [Abstract] [Full Text] [Related]

  • 40. Cardiopulmonary effects of recombinant interleukin-2 infusion in sheep.
    Glauser FL, DeBlois GG, Bechard DE, Merchant RE, Grant AJ, Fowler AA, Fairman RP.
    J Appl Physiol (1985); 1988 Mar 15; 64(3):1030-7. PubMed ID: 3259225
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.